MTOR and focal segmental glomerulosclerosis: In BHDS patients, maintenance therapy with mTOR inhibitors might be considered after the initial wound-healing period but should be done so with caution due to the risk of podocyte apoptosis and potential development of focal segmental glomerulosclerosis.